Repligen Corporation
RGEN
$155.70
-$4.41-2.75%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/6/2025
-
GuruFocus
3/6/2025
-
Ticker Report
3/6/2025
-
MarketBeat
3/5/2025
-
The Online Investor
3/5/2025
-
TipRanks Financial Blog
3/4/2025
-
TipRanks Financial Blog
3/4/2025
-
The Fly
3/4/2025
-
Seeking Alpha - Healthcare
3/4/2025
-
SeekingAlpha.com: All News
3/4/2025
-
GuruFocus
3/4/2025
-
GuruFocus
3/4/2025
-
GuruFocus
3/4/2025
-
The Fly
3/4/2025
-
The Fly
3/4/2025
-
Globe Newswire
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
MarketBeat
2/26/2025
-
Ticker Report
2/25/2025
-
GuruFocus
2/24/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/24/2025
-
MarketBeat
2/23/2025
-
MarketBeat
2/22/2025
-
MarketBeat
2/22/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 18, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Nov 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 250 0111
Address
Building 1
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and...
more
